Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
Clinical trial NCT03490942 · TERMINATED
Trial details
- NCT number
- NCT03490942
- Sponsor
- Xeris Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2019-11-04
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.